Canopy A

Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A (Canopy-A)

PD-L1

aktiv

3

Lungenkrebszentrum Ostercappeln, Sektion Thoraxchirurgie, Franziskus Hospital Harderberg

Niels Stensen Kliniken
Alte Rothenfelder Strasse 23
49124 Georgsmarienhütte

Dr. Petra Hoffknecht
Franziskus Hospital Harderberg

Vorherige Studie
Nächste Studie
to top icon